Loading...

BIO-Key International Inc
NASDAQ:BKYI

Watchlist Manager
BIO-Key International Inc Logo
BIO-Key International Inc
NASDAQ:BKYI
Watchlist
Price: 0.95 USD -5% Market Closed
Updated: Dec 6, 2022

Intrinsic Value

BKYI doesn't have a meaningful market cap.

The intrinsic value of one BKYI stock under the Base Case scenario is 6.07 USD. Compared to the current market price of 0.95 USD, BIO-Key International Inc is Undervalued by 84%.

The Intrinsic Value is calculated as the average of the two valuation methods:

BKYI Intrinsic Value
Base Case
6.07 USD
Undervaluation 84%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

BKYI Profitability Score
Profitability Due Diligence

BIO-Key International Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Negative 3-Year Average ROE
Negative 3-Year Average ROIC
Negative Free Cash Flow
Negative Operating Income
30/100
Profitability
Score

BIO-Key International Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

BKYI Solvency Score
Solvency Due Diligence

BIO-Key International Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Low Interest Coverage
Low Altman Z-Score
Short-Term Liabilities
Low D/E
53/100
Solvency
Score

BIO-Key International Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
71%
Gross Margin
-112%
Operating Margin
-115%
Net Margin
-101%
FCF Margin
-50%
ROE
-66%
ROIC
Other

BKYI Capital Structure
BIO-Key International Inc

Market Capitalization 8M USD
Total Debt 322k USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 2.8M USD
Short-Term Investments 0 USD
Enterprise Value 5.6M USD

Wall St
Price Targets

BKYI Price Targets Summary
BIO-Key International Inc

Wall Street analysts forecast BKYI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BKYI is 4.08 USD with a low forecast of 4.04 USD and a high forecast of 4.2 USD.

Lowest
Price Target
4.04 USD
325% Upside
Average
Price Target
4.08 USD
329% Upside
Highest
Price Target
4.2 USD
342% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

BKYI Competitors
BIO-Key International Inc

BKYI Suppliers & Customers
BIO-Key International Inc

BIO-Key International Inc has 5 key suppliers from 1 countries and 3 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Technology industry.

BIO-Key International Inc has 8 key customers from 2 countries and 4 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.

Ownership

BKYI Insider Trading
Buy and sell transactions by insiders

BIO-Key International Inc insiders have only bought shares in the past 12 months.

During the last 12 months BIO-Key International Inc insiders bought 35.5k USD , and have not sold any shares. The last transaction was made on Dec 6, 2022 by Depasquale Michael W (Chairman), who bought 1.7k USD worth of BKYI shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
2
13.1k USD
3-6
months
2
17.8k USD
6-9
months
1
4.5k USD
9-12
months
No Insider Transactions
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
N/A
13.1k USD
13.1k
6 Months
N/A
31k USD
31k
9 Months
N/A
35.5k USD
35.5k
12 Months
N/A
35.5k USD
35.5k
Purchases
48
Sales
0
Why is insider trading important?

Shareholder Return

BKYI Price
BIO-Key International Inc

1M 1M
-39%
6M 6M
-48%
1Y 1Y
-59%
3Y 3Y
-82%
5Y 5Y
-92%
Annual Price Range
0.95
52w Low
0.93
52w High
2.82
Price Metrics
Average Annual Return -19.55%
Standard Deviation of Annual Returns 35.95%
Max Drawdown -96%
Shares Statistics
Market Capitalization 8M USD
Shares Outstanding 8 450 990
Percentage of Shares Shorted 1%

Company Profile

BIO-Key International Inc

Country

United States of America

Industry

Technology

Market Cap

8M USD

Dividend Yield

0%

Description

BIO-key International, Inc. engages in the provision of identity and access management (IAM) platform. The company is headquartered in Wall Township, New Jersey and currently employs 51 full-time employees. The firm's products include PortalGuard and PortalGuard identity-as-a-service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, and accessory hardware to customers. PortalGuard IDaaS offers flexible single sign-on and authentication options to meet users' security goals and deliver an optimized user experience. WEB-key is a scalable biometric service management platform, incorporating key functions for regulatory compliance, enrollment, authentication or identification, and integrity in a multi-tenant private or public cloud delivery platform. The company also offers biometric software integration application programming interfaces (APIs), allowing software developers to leverage its platform to securely embed biometric multi-factor authentication (MFA), into their own products.

Contact

NEW JERSEY
Wall Township
3349 State Route 138 Ste E
+18668462594.0
http://www.bio-key.com/

IPO

1997-04-17

Employees

51

Officers

Chairman & CEO
Mr. Michael W. DePasquale
Chief Technology Officer
Ms. Mira K. LaCous
Sr. VP of Strategy & Compliance and Chief Legal Officer
Mr. James David Sullivan
MD of Hong Kong & Vice-Chairman
Mr. Kwok Fong Wong
Chief Financial Officer
Ms. Cecilia C. Welch
Chief Revenue Officer
Mr. Frederick Corsentino
Show More
Managing Director of Africa
Mr. Akintunde Carlton Jeje
Managing Director of EMEA
Mr. Alex Rocha
Pres of PortalGuard
Mr. Mark Cochran
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one BKYI stock?

The intrinsic value of one BKYI stock under the Base Case scenario is 6.07 USD.

Is BKYI stock undervalued or overvalued?

Compared to the current market price of 0.95 USD, BIO-Key International Inc is Undervalued by 84%.